| The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial AA Voors, CE Angermann, JR Teerlink, SP Collins, M Kosiborod, J Biegus, ... Nature medicine 28 (3), 568-574, 2022 | 530 | 2022 |
| The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial ME Nassif, SL Windsor, BA Borlaug, DW Kitzman, SJ Shah, F Tang, ... Nature medicine 27 (11), 1954-1960, 2021 | 415 | 2021 |
| Dapagliflozin effects on biomarkers, symptoms, and functional status in patients with heart failure with reduced ejection fraction: the DEFINE-HF trial ME Nassif, SL Windsor, F Tang, Y Khariton, M Husain, SE Inzucchi, ... Circulation 140 (18), 1463-1476, 2019 | 383 | 2019 |
| Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial MN Kosiborod, R Esterline, RHM Furtado, J Oscarsson, SB Gasparyan, ... The lancet Diabetes & endocrinology 9 (9), 586-594, 2021 | 208 | 2021 |
| Empagliflozin effects on pulmonary artery pressure in patients with heart failure: results from the EMBRACE-HF trial ME Nassif, M Qintar, SL Windsor, R Jermyn, DM Shavelle, F Tang, ... Circulation 143 (17), 1673-1686, 2021 | 173 | 2021 |
| Association of serial Kansas City Cardiomyopathy Questionnaire assessments with death and hospitalization in patients with heart failure with preserved and reduced ejection … Y Pokharel, Y Khariton, Y Tang, ME Nassif, PS Chan, SV Arnold, ... JAMA cardiology 2 (12), 1315-1321, 2017 | 151 | 2017 |
| The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial JA Spertus, MC Birmingham, M Nassif, CV Damaraju, A Abbate, J Butler, ... Nature medicine 28 (4), 809-813, 2022 | 148 | 2022 |
| Relationship between anticoagulation intensity and thrombotic or bleeding outcomes among outpatients with continuous-flow left ventricular assist devices ME Nassif, SJ LaRue, DS Raymer, E Novak, JM Vader, GA Ewald, ... Circulation: Heart Failure 9 (5), e002680, 2016 | 101 | 2016 |
| Effects of empagliflozin on symptoms, physical limitations, and quality of life in patients hospitalized for acute heart failure: results from the EMPULSE trial MN Kosiborod, CE Angermann, SP Collins, JR Teerlink, P Ponikowski, ... Circulation 146 (4), 279-288, 2022 | 99 | 2022 |
| Systolic blood pressure on discharge after left ventricular assist device insertion is associated with subsequent stroke ME Nassif, A Tibrewala, DS Raymer, A Andruska, E Novak, JM Vader, ... The Journal of Heart and Lung Transplantation 34 (4), 503-508, 2015 | 97 | 2015 |
| Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial J Biegus, AA Voors, SP Collins, MN Kosiborod, JR Teerlink, ... European Heart Journal 44 (1), 41-50, 2023 | 93 | 2023 |
| Health status disparities by sex, race/ethnicity, and socioeconomic status in outpatients with heart failure Y Khariton, ME Nassif, L Thomas, GC Fonarow, X Mi, AD DeVore, C Duffy, ... JACC: Heart Failure 6 (6), 465-473, 2018 | 93 | 2018 |
| Sodium–glucose co‐transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial J Tromp, P Ponikowski, A Salsali, CE Angermann, J Biegus, J Blatchford, ... European journal of heart failure 23 (5), 826-834, 2021 | 89 | 2021 |
| Intra-aortic balloon counterpulsation in patients with chronic heart failure and cardiogenic shock: clinical response and predictors of stabilization MA Sintek, M Gdowski, BR Lindman, M Nassif, KJ Lavine, E Novak, ... Journal of cardiac failure 21 (11), 868-876, 2015 | 89 | 2015 |
| Clinical outcomes associated with INTERMACS-defined right heart failure after left ventricular assist device implantation SJ LaRue, DS Raymer, BR Pierce, ME Nassif, CT Sparrow, JM Vader The Journal of Heart and Lung Transplantation 36 (4), 475-477, 2017 | 84 | 2017 |
| Usefulness of psoas muscle area determined by computed tomography to predict mortality or prolonged length of hospital stay in patients undergoing left ventricular assist … GA Heberton, M Nassif, A Bierhals, E Novak, SJ LaRue, B Lima, S Hall, ... The American journal of cardiology 118 (9), 1363-1367, 2016 | 75 | 2016 |
| Pre-operative right ventricular dysfunction is associated with gastrointestinal bleeding in patients supported with continuous-flow left ventricular assist devices CT Sparrow, ME Nassif, DS Raymer, E Novak, SJ LaRue, JD Schilling JACC: Heart Failure 3 (12), 956-964, 2015 | 72 | 2015 |
| Systemic inflammatory response syndrome after transcatheter or surgical aortic valve replacement BR Lindman, JS Goldstein, ME Nassif, A Zajarias, E Novak, A Tibrewala, ... Heart 101 (7), 537-545, 2015 | 68 | 2015 |
| In-hospital initiation of sodium-glucose cotransporter-2 inhibitors for heart failure with reduced ejection fraction VN Rao, E Murray, J Butler, LB Cooper, ZL Cox, M Fiuzat, JB Green, ... Journal of the American College of Cardiology 78 (20), 2004-2012, 2021 | 65 | 2021 |
| Prospective assessment of frailty using the fried criteria in patients undergoing left ventricular assist device therapy SM Joseph, JL Manghelli, JM Vader, T Keeney, EL Novak, J Felius, ... The American journal of cardiology 120 (8), 1349-1354, 2017 | 61 | 2017 |
Mikhail KosiborodSaint Luke's Mid America Heart Institute在 saint-lukes.org 的电子邮件经过验证
